SDF4 Human Pre-designed siRNA Set A contains three designed siRNAs for SDF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDH-IN-12 (compound 9b) is a succinate dehydrogenase inhibitor, which exhibits activity against S. sclerotiorum and C. arachidicola, with EC50s of 0.97 and 2.07 μM, respectively. SDH-IN-12 reveals no significant herbicidal activity against monocotyledonous and dicotyledonous plants[1].

SDH-IN-13 (Compound 5IIIh) is a SDH inhibitor (IC50: 13.7 μg/mL) and an antifungal agent[1].

SDH-IN-14 (Compound Z2) is an inhibitor of succinate dehydrogenase (SDH). SDH-IN-14 has antifungal activity (EC50=2.7 μg/mL) against B.cinerea. SDH-IN-14 acts by disrupting the integrity of the cell wall and cell membrane[1].

SDH-IN-15 (Compound 5e) is an inhibitor of succinate dehydrogenase (SDH) (IC50=2.04 μM). SDH-IN-15 has significant antifungal activity. SDH-IN-15 blocks the mitochondrial respiratory chain of the fungus through inhibition of SDH, resulting in fungal death[1].

SDHA Human Pre-designed siRNA Set A contains three designed siRNAs for SDHA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDHAF1 Human Pre-designed siRNA Set A contains three designed siRNAs for SDHAF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDHAF2 Human Pre-designed siRNA Set A contains three designed siRNAs for SDHAF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDHB Human Pre-designed siRNA Set A contains three designed siRNAs for SDHB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDHC Human Pre-designed siRNA Set A contains three designed siRNAs for SDHC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDHD Human Pre-designed siRNA Set A contains three designed siRNAs for SDHD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDI-118 is an orally active modulator for synaptic vesicle glycoprotein 2A (SV2A) with an IC50 of 13 nM[1].

SDK2 Human Pre-designed siRNA Set A contains three designed siRNAs for SDK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDR16C5 Human Pre-designed siRNA Set A contains three designed siRNAs for SDR16C5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDR9C7 Human Pre-designed siRNA Set A contains three designed siRNAs for SDR9C7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDS Human Pre-designed siRNA Set A contains three designed siRNAs for SDS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDSL Human Pre-designed siRNA Set A contains three designed siRNAs for SDSL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SDU-071 is a potent and orally active inhibitor of BRD4-p53 inhibitor. SDU-071 inhibits MDA-MB-231 cells proliferation with an IC50 of 10.5 μM. SDU-071 induces cell cycle arrest and apoptosis[1].

SDX-7539 is a selective inhibitor for Methionine aminopeptidase type 2 (MetAP2). SDX-7539 inhibits proliferarion of HUVECs with an IC50 of 120 μM. SDX-7539 exhibits antitumor activity in NSCLC xenograft athymic nude mice[1].

SE-7552, a 2-(difluoromethyl)-1,3,4-oxadiazole (DFMO) derivative, is an orally active, highly selective, non-hydroxamate HDAC6 inhibitor with an IC50 of 33 nM. SE-7552 is greater than 850-fold selectivity versus all other known HDAC isozymes. SE-7552 is capable of blocking multiple myeloma growth in vivo. SE-7552 acts as an anti-obesity agent in diet-induced obese mice[1][2].

SE-7552, a 2-(difluoromethyl)-1,3,4-oxadiazole (DFMO) derivative, is an orally active, highly selective, non-hydroxamate HDAC6 inhibitor with an IC50 of 33 nM. SE-7552 is greater than 850-fold selectivity versus all other known HDAC isozymes. SE-7552 is capable of blocking multiple myeloma growth in vivo. SE-7552 acts as an anti-obesity agent in diet-induced obese mice[1][2].

SE-7552, a 2-(difluoromethyl)-1,3,4-oxadiazole (DFMO) derivative, is an orally active, highly selective, non-hydroxamate HDAC6 inhibitor with an IC50 of 33 nM. SE-7552 is greater than 850-fold selectivity versus all other known HDAC isozymes. SE-7552 is capable of blocking multiple myeloma growth in vivo. SE-7552 acts as an anti-obesity agent in diet-induced obese mice[1][2].

SE-7552, a 2-(difluoromethyl)-1,3,4-oxadiazole (DFMO) derivative, is an orally active, highly selective, non-hydroxamate HDAC6 inhibitor with an IC50 of 33 nM. SE-7552 is greater than 850-fold selectivity versus all other known HDAC isozymes. SE-7552 is capable of blocking multiple myeloma growth in vivo. SE-7552 acts as an anti-obesity agent in diet-induced obese mice[1][2].

SE-7552, a 2-(difluoromethyl)-1,3,4-oxadiazole (DFMO) derivative, is an orally active, highly selective, non-hydroxamate HDAC6 inhibitor with an IC50 of 33 nM. SE-7552 is greater than 850-fold selectivity versus all other known HDAC isozymes. SE-7552 is capable of blocking multiple myeloma growth in vivo. SE-7552 acts as an anti-obesity agent in diet-induced obese mice[1][2].

SEA Human Pre-designed siRNA Set A contains three designed siRNAs for SEA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEBOX Human Pre-designed siRNA Set A contains three designed siRNAs for SEBOX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sec-butyl butyrate-d2 is deuterated labeled 5-Octyldihydrofuran-2(3H)-one.

SEC11A Human Pre-designed siRNA Set A contains three designed siRNAs for SEC11A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC11C Human Pre-designed siRNA Set A contains three designed siRNAs for SEC11C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC13 Human Pre-designed siRNA Set A contains three designed siRNAs for SEC13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC14L1 Human Pre-designed siRNA Set A contains three designed siRNAs for SEC14L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC14L2 Human Pre-designed siRNA Set A contains three designed siRNAs for SEC14L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC14L3 Human Pre-designed siRNA Set A contains three designed siRNAs for SEC14L3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC16A Human Pre-designed siRNA Set A contains three designed siRNAs for SEC16A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC16B Human Pre-designed siRNA Set A contains three designed siRNAs for SEC16B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC22B Human Pre-designed siRNA Set A contains three designed siRNAs for SEC22B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC23A Human Pre-designed siRNA Set A contains three designed siRNAs for SEC23A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC23B Human Pre-designed siRNA Set A contains three designed siRNAs for SEC23B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC23IP Human Pre-designed siRNA Set A contains three designed siRNAs for SEC23IP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC24A Human Pre-designed siRNA Set A contains three designed siRNAs for SEC24A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC24B Human Pre-designed siRNA Set A contains three designed siRNAs for SEC24B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC24C Human Pre-designed siRNA Set A contains three designed siRNAs for SEC24C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC24D Human Pre-designed siRNA Set A contains three designed siRNAs for SEC24D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC31A Human Pre-designed siRNA Set A contains three designed siRNAs for SEC31A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC31B Human Pre-designed siRNA Set A contains three designed siRNAs for SEC31B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEC61A1 Human Pre-designed siRNA Set A contains three designed siRNAs for SEC61A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.